Onderneming 4D Molecular Therapeutics, Inc.
Aandelen
FDMT
US35104E1001
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
23,25 USD | -1,19% | -7,92% | +14,76% |
15/04 | 4D MOLECULAR THERAPEUTICS, INC. : Barclays bevestigt koopadvies | ZM |
15/04 | 4D MOLECULAR THERAPEUTICS, INC. : RBC Capital Markets geeft koopadvies | ZM |
Vakgebied
Aantal werknemers: 147
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Gene Therapeutic Products
100,0
%
| 3 | 100,0 % | 21 | 100,0 % | +562,29% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
97,3
%
| 0 | 1,1 % | 20 | 97,3 % | +57.488,57% |
Netherlands
2,7
%
| 3 | 98,9 % | 1 | 2,7 % | -81,67% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Theresa Janke
FOU | Founder | 49 | 12-09-13 |
David Kirn
FOU | Founder | 62 | 12-09-13 |
Uneek Mehra
DFI | Director of Finance/CFO | - | 12-09-23 |
Fariborz Kamal
PSD | President | 61 | 01-10-18 |
Robert Kim
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-10-22 |
Chief Tech/Sci/R&D Officer | 62 | 23-09-22 | |
Julian Pei
IRC | Investor Relations Contact | - | - |
Scott Bizily
HRO | Human Resources Officer | 52 | 01-09-21 |
An Song
PRN | Corporate Officer/Principal | - | 01-09-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 01-08-20 |
Susannah Gray
BRD | Director/Board Member | 63 | 01-07-20 |
Charles Theuer
BRD | Director/Board Member | 60 | 01-01-16 |
David Kirn
FOU | Founder | 62 | 12-09-13 |
Jacob Chacko
BRD | Director/Board Member | 45 | 01-03-19 |
Shawn Tomasello
BRD | Director/Board Member | 65 | 18-11-20 |
Director/Board Member | 65 | 18-11-20 | |
Chief Tech/Sci/R&D Officer | 62 | 23-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 51 157 472 | 49 349 028 ( 96,46 %) | 0 | 96,46 % |
Bedrijfsgegevens
4D Molecular Therapeutics, Inc.
5858 Horton Street Suite 455
94608, Emeryville
+
http://www.4dmoleculartherapeutics.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,76% | 1,19 mld. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers FDMT
- Onderneming 4D Molecular Therapeutics, Inc.